BioAge Labs, Inc.
Company Stats
- Market Cap
- $325.4M
- as of Sep 30, 2026
- Enterprise Value
- $138.5M
- Shares Outstanding
- 45.9M
- Free Float
- 78.4%
Income Statement
- Revenue
- $9.0M
- Operating Income
- -$92.8M
- Net Income
- -$80.6M
- EBITDA
- -$92.6M
Cash Flow
- Free Cash Flow
- -$82.3M
- FCF Yield
- -25.3%
- Owner FCF Yield
- -28.9%
Balance Sheet
- Cash & Equivalents
- $188.9M
- Total Debt
- $2.0M
- Net Cash
- $186.9M
Returns & Capital
- SBC, 3Y Avg
- $7.2M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $9.0M | -$82.3M | -915.5% |
| FY2024 | $0 | -$51.9M | — |
| FY2023 | — | -$37.5M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back